Could You Have Seen The Run In Tempus AI Stock Coming?
Tempus AI (TEM) stock returned 56.9% in the six months from April 9 to October 8, 2026. Partway through that timeline, on July 30, the company finally reported a quarterly profit following years of losses. Yet the stock’s run began more than three months before that earnings report. Market moves of this scale always look obvious in hindsight. Had Tempus signaled that positive net income—or breakeven on an adjusted basis—was finally within reach?
Tempus Was Talking About Break-Even Long Before The Run
Yes, and the company broadcast its intentions early. During the fiscal Q3 2024 earnings call on November 4, 2024, executives stated Tempus was on a “march toward cash flow and adjusted breakeven.” That statement came seventeen months before the run began.
Investors could not have traded solely on that phrase, since goals are easy for executives to declare. It did, however, provide a specific metric to track in subsequent filings: a shrinking quarterly loss.
Losses At Tempus Narrowed Through 2025
The financial reports filed throughout 2025 showed exactly that progression. In a report filed on May 6, 2025, the company disclosed its operating loss was 26.9% of revenue for the first quarter of 2025. That deficit narrowed over each of the next three quarters, settling at 16.7% of revenue in the fourth quarter of 2025. Revenue in that same fourth quarter was 83.0% higher than a year earlier. This meant Tempus was steadily reducing its loss as a share of revenue while maintaining rapid growth. The company filed that fourth-quarter report on February 24, 2026, more than six weeks before the run began.
Those filings alone did not provide perfect timing for the market move. Tempus stock had reached $100 in October 2025, and the run began in April 2026 at less than half that price. The operating loss was shrinking the entire time the share price fell. The underlying financial improvement was visible, but anyone who bought the stock at $100 in October 2025 had to endure a heavy decline first.
Tempus Beat The S&P 500 And Reported Quarterly Profit
The S&P 500 returned 14.4% over the same six months, meaning Tempus outperformed the broader market by a wide margin. The company was not acting in isolation, however. Guardant Health and Natera, two of its listed peers, each returned about 90% over the same window. Those peers rose even more than Tempus did, which suggests investors repriced the entire group.
The clearest confirmation from Tempus itself arrived on July 30, 2026. On the fiscal Q2 2026 call, management reported GAAP net income of $5.6 million on revenue of $382.5 million. While that profit is thin against sales of that size, it is a profit, though it came right after a first quarter of 2026 in which the net loss had widened.
Is Tempus Still Moving Toward Break-Even Today?
Yes, but the process is ongoing. A single profitable quarter has not erased the historical deficits. Over the latest twelve months, Tempus still shows a net loss of 17.8% of revenue, measured against 21% a year earlier, confirming the loss continues to shrink. Cash generation remains the unrealized portion of the November 2024 goal. Tempus used $7.5 million of cash in its operations in fiscal Q2 2026, though management noted on the July 30 call that it expects positive free cash flow by year-end.
Meanwhile, the top line is expanding more slowly than it did before the stock’s run. Revenue grew 21.6% in the latest quarter, compared to 83.0% in the fourth quarter of 2025. During the July 30 call, management noted that growth in hereditary cancer testing had slowed, while its data licensing and modeling business grew 36%.
Generating positive free cash flow by the end of 2026 would prove Tempus reached the break-even target it established in November 2024. A negative figure would indicate it fell short.
How To Act On TEM?
Now you know TEM better. And that’s our purpose: to make you informed before you invest your money. However, making a bet on a single stock carries its own risks.
There is a smarter choice. Since its inception, the Trefis High Quality (HQ) Portfolio has beaten the benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. And it did so without taking the concentrated risk that comes with do-it-yourself stock picking.
If you’d rather act on TEM itself:
| Play Offense | Play Defense |
|---|---|
| Learn More About TEM & Invest | Save Taxes On Capital Gain |
| Earn From TEM Cash Secured Puts | Covered Call Against TEM |